CLEARFP IP, LLC – Trademark Portfolio
Entity Type: 16
CLEARFP IP, LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 5 filings in this category. The portfolio also extends into Class 16 (Paper Goods) across 3 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include CLEARFP, CLEAR FINANCIAL PARTNERS, and C CLEAR FINANCIAL PARTNERS. The owner is based in LAKE OSWEGO, OR.
15573 Bangy Road
LAKE OSWEGO, OR 97035
Showing of trademarks Trademarks
Trademark Classifications
CLEARFP IP, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does CLEARFP IP, LLC have?
CLEARFP IP, LLC has 7 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending, 2 abandoned, 1 cancelled.
What trademark classes does CLEARFP IP, LLC file in?
CLEARFP IP, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 16 (Paper Goods), Class 42 (Computer & Scientific). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are CLEARFP IP, LLC's most well-known trademarks?
CLEARFP IP, LLC's registered trademark portfolio includes well-known marks such as CLEARFP, CLEAR FINANCIAL PARTNERS, and C CLEAR FINANCIAL PARTNERS. These are among 3 currently registered trademarks in the portfolio.
What is CLEARFP IP, LLC's trademark registration success rate?
CLEARFP IP, LLC has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 1 application is pending review.